Oleuropein Induces Anti-metastatic Effects in Breast Cancer

被引:64
作者
Hassan, Zeinab K. [1 ,2 ]
Elamin, Maha H. [1 ]
Daghestani, Maha H. [1 ]
Omer, Sawsan A. [1 ]
Al-Olayan, Ebtesam M. [1 ]
Elobeid, Mai A. [1 ]
Virk, Promy [1 ]
Mohammed, Osama B. [1 ,3 ]
机构
[1] King Saud Univ, Coll Sci, Dept Zool, Univ Ctr Women Students, Riyadh 11451, Saudi Arabia
[2] Cairo Univ, Dept Canc Biol, Natl Canc Inst, Cairo, Egypt
[3] Cairo Univ, KSU Mammals Res Chair, Cairo, Egypt
关键词
Breast cancer; oleuropein; metastasis; TIMPs expression; MMPs expression; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASES; OLIVE OIL; BIOLOGICAL-ACTIVITIES; BITTER PRINCIPLE; PROGNOSTIC VALUE; MELANOMA-CELLS; MESSENGER-RNAS; IN-VITRO; EXPRESSION;
D O I
10.7314/APJCP.2012.13.9.4555
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Breast cancer causes death due to distant metastases in which tumor cells produce matrix metalloproteinase (MMP) enzymes which facilitate invasion. Oleuropein, the main olive oil polyphenol, has anti-proliferative effects. This study aimed to investigate the effect of oleuropein on the metastatic and anti-metastatic gene expression in the MDA human breast cancer cell line. We evaluated the MMPs and TIMPs gene expression by semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) in treated and untreated cells. This study demonstrated that OL may induce anti-metastatic effects on human breast cancer cells. We found that TIMP1,-3, and -4 were over-expressed after all periods of incubation in treated cancer cells compared to untreated cells, while MMP2 and MMP9 genes were down-regulated, at least initially. Treatment of breast cancer cells with oleuropein could help in prevention of cancer metastasis by increasing the TIMPs and suppressing the MMPs gene expressions.
引用
收藏
页码:4555 / 4559
页数:5
相关论文
共 47 条
[1]
Olive Oil Polyphenol Oleuropein Inhibits Smooth Muscle Cell Proliferation [J].
Abe, R. ;
Beckett, J. ;
Abe, R. ;
Nixon, A. ;
Rochier, A. ;
Yamashita, N. ;
Sumpio, B. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2011, 41 (06) :814-820
[2]
Baker EA, 2002, J CLIN PATHOL-MOL PA, V55, P300
[3]
Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions:: an in situ hybridization study [J].
Brummer, O ;
Athar, S ;
Riethdorf, L ;
Löning, T ;
Herbst, H .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (06) :566-573
[4]
The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice [J].
Buck, TB ;
Yoshiji, H ;
Harris, SR ;
Bunce, OR ;
Thorgeirsson, UP .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :732-735
[5]
Novel functions of TIMPs in cell signaling [J].
Chirco, R ;
Liu, XW ;
Jung, KK ;
Kim, HRC .
CANCER AND METASTASIS REVIEWS, 2006, 25 (01) :99-113
[6]
Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits [J].
Coni, E ;
Di Benedetto, R ;
Di Pasquale, M ;
Masella, R ;
Modesti, D ;
Mattei, R ;
Carlini, EA .
LIPIDS, 2000, 35 (01) :45-54
[7]
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers [J].
Curran, S ;
Dundas, SR ;
Buxton, J ;
Leeman, MF ;
Ramsay, R ;
Murray, GI .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8229-8234
[8]
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas [J].
Decock, J. ;
Hendrickx, W. ;
Drijkoningen, M. ;
Wildiers, H. ;
Neven, P. ;
Smeets, A. ;
Paridaens, R. .
DISEASE MARKERS, 2007, 23 (03) :189-196
[9]
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential [J].
Figueira, Rita C. S. ;
Gomes, Luciana R. ;
Neto, Joao S. ;
Silva, Fabricio C. ;
Silva, Ismael D. C. G. ;
Sogayar, Mari C. .
BMC CANCER, 2009, 9
[10]
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or-2 [J].
Finan, Katherine M. ;
Hodge, Greg ;
Reynolds, Ann M. ;
Hodge, Sandra ;
Holmes, Mark D. ;
Baker, Andrew H. ;
Reynolds, Paul N. .
LUNG CANCER, 2006, 53 (03) :273-284